Navigation Links
Zeus to Present at Digestive Disease Week in Chicago
Date:5/29/2009

Zeus Research & Development will be one of the presenters at Digestive Disease Week, addressing the topic of invention of new devices in interventional gastroenterology.

Orangeburg, SC (PRWEB) May 29, 2009 -- Zeus, Inc., a leader in polymer extrusions and material science, announces it has been invited to present at Digestive Disease Week in Chicago on June 1, 2009. Zeus presenters, Dr. Bruce Anneaux, Ph.D. and GI Endoscopy Specialist Aubrey Sanders, will address possible polymer selection for building new and innovative medical devices for interventional procedures in gastrointestinal endoscopy and Natural Orifice Translumenal Endoscopic Surgery (NOTES).

Digestive Disease Week is the world's largest meeting of researches, physicians, and other professionals in the fields of gastroenterology, endoscopy, gastrointestinal surgery, and hepatology.

When Dr. Naomi Nakao, a prolific inventor of 20 years extended her invitation to Zeus to speak at the conference, she prefaced her invitation as follows: "Being an inventor can be a lonely journey, but Zeus has faithfully stood by me for these many years. Zeus engineers have generously helped me during my research and development of the many prototypes of my inventions. I was gently brought down to earth by Zeus engineers, learning what is, and is not possible in building my devices. Sharing their company's varied capabilities, I learned from Zeus' engineers that things I did not think possible could be built because of the enormous imagination that Zeus puts into its colossal ensemble of shapes, forms, colors, and sizes of the catheters and other sub-components that it has to offer."

The Zeus presentation will focus primarily on developing industry advancements in polymer science with an emphasis on gastroenterology and endoscopy of the present and future. At the conclusion of the presentation, Dr. Anneaux and Ms. Sanders will participate in an open panel discussion.

Commenting on his presentation Dr. Bruce Anneaux, Corporate Manager, Research & Development for Zeus, said, "We are excited about the opportunity to present at a gathering of this scope and significance. Both the Zeus presentation and open panel discussion seek to enhance attendees' understanding of polymer selection and create an open dialogue among the innovators in gastroenterology/endoscopy medical device industry."

Bob Jennings, Vice President for Medical Sales and Marketing, said, "Zeus has an evolving history of exploring and advancing innovative concepts and processes in the medical device industry. It is this commitment that allows us to serve as a resource for inventors, physicians, and other professionals who strive to enhance medical applications and ultimately, improve patient care."

About Zeus, Inc.:
Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in material science and the development of high-performance polymer tubing used in demanding applications; operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, and mechanical markets. For more information, visit www.zeusinc.com.

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2473274.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Delaware Urologic Associate's, Dr. Peter J. Muench, Presents Advances in Incontinence Treatment with a New Perspective and Outlook
2. AGA Institute presents cutting-edge research during DDW
3. IDEXX Laboratories to Present at William Blair 29th Annual Growth Stock Conference
4. The Pediatric IBD Center at Cedars-Sinai Medical Center Presents Rock-n-Reel 2009 Honoring Alexandra Milchan-Lambert & Scott Lambert
5. Process for Planning Safe Pain Treatment Outlined in Presentation at FDA Meeting
6. DDL, Leader in Medical Device Package, Product and Material Testing, will be Presenting at This Year's MD&M Show in New York
7. Liu Young Investigator Award presented to Kevin Bruhn, Ph.D.
8. Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009
9. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
10. Bioniche Represented at House of Commons Sub-Committee on Food Safety
11. PAREXEL International to Present at Goldman Sachs Annual Global Healthcare Conference and the Jefferies Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... 2017 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that Mr. Michael Merges, Director of Strategic Growth, Catalent Biologics ... at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, 2017. , ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... the first time support an aid project with the donation of cochlear implants. ... the gift of hearing and thus a fair chance of leading an independent ...
(Date:1/18/2017)... CA (PRWEB) , ... January 18, 2017 , ... ... dental problems ranging from gum disease to enamel erosion, and those dental problems ... Massachusetts Department of Public Health, many pregnant women are failing to get the ...
(Date:1/17/2017)... ... January 17, 2017 , ... January is National Stalking Awareness Month (NSAM), ... lurk in the corners and commit the crime of stalking, a very real danger to ... an often overlooked factor in stalking and other crimes. , “Stalking: know it. Name it. ...
(Date:1/17/2017)... ... 2017 , ... Gym Source, America’s leading retailer of premium residential and commercial ... in Miami, FL. , “We are elated to be opening this new showroom,” explains ... designed to give clients a seamless and motivating shopping experience.” , Every fitness journey ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... January 17, 2017 Management to Discuss ... Ltd.   KIT-302 Development On Track For An ... in Q1 2017   ... Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), an ... Monday, January 23 rd at 8:30am Eastern Time to discuss the recent ...
(Date:1/17/2017)... , Jan. 17, 2017  Jazz Pharmaceuticals plc (Nasdaq: ... patient has been enrolled in a Phase 3 clinical ... best supportive care (BSC) in the prevention of hepatic ... hematopoietic stem cell transplant (HSCT) who are at high ... The defibrotide clinical trial will be conducted across approximately ...
(Date:1/17/2017)... 2017  Edwards Lifesciences Corporation (NYSE: EW ... heart disease and critical care monitoring, plans to announce ... 2016 after the market closes on Wednesday, February 1, ... p.m. ET that day to discuss those results. ... 407-8037 or (201) 689-8037.  For 72 hours following the ...
Breaking Medicine Technology: